Role of PRF With MTA and Theracal After Pulpotomy in Relieving Pain

August 19, 2019 updated by: Sarah Essam, Cairo University

Role of PRF With MTA and Theracal After Pulpotomy in Relieving Pain and Maintaining the Vitality of the Remaining Radicular Pulp Tissue in Permanent Posterior Teeth With Closed Root Apices: "Randomized Controlled Trial"

this research will evaluate the effect of PRF with different bioactive materials in dentistry

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

PRF will be used with MTA and Theracal to evaluate its effect upon these materials in reliving pain and maintains the teeth vitality in permanent teeth with closed apices, in order to improve the materials outcome.

Study Type

Interventional

Enrollment (Anticipated)

98

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients suffering from Symptomatic pulpitis.
  • Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
  • Patients who will agree to the consent and will commit to follow-up period.
  • Patients with mature root.
  • Patients with no periapical lesion.
  • Patients with localized pain.
  • Posterior teeth only will be involved

Exclusion Criteria:

  • Patients with immature roots.
  • Patients with any systemic disease that may affect normal healing.
  • Patients with periapical lesions or infections.
  • Pregnant females.
  • Patients who could/would not participate in a 1-year follow-up.
  • Patients with fistula.
  • Patients with necrotic pulp.
  • Patients with old age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PRF with MTA
PRF with MTA with PRF with Theracal as intervention
using the PRF which is a new technique with an bioactive material which is the Theracal to evaluate its effect upon the radicular pulp tissue

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain after the process
Time Frame: 1 year
Questionnaire by asking the patient about the pain intensity
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
dentin bridge formation
Time Frame: 1 year
X-ray
1 year
no periapical radiolucency
Time Frame: 1 year
X-ray
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 22, 2019

Primary Completion (Anticipated)

August 22, 2019

Study Completion (Anticipated)

September 30, 2019

Study Registration Dates

First Submitted

March 12, 2018

First Submitted That Met QC Criteria

April 3, 2018

First Posted (Actual)

April 10, 2018

Study Record Updates

Last Update Posted (Actual)

August 20, 2019

Last Update Submitted That Met QC Criteria

August 19, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • CEBD-CU-2018-03-07

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuritis

Clinical Trials on PRF with Theracal

3
Subscribe